Black Diamond Therapeutics (BDTX) Insider Trading & Ownership $2.55 +0.01 (+0.39%) (As of 08:33 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Black Diamond Therapeutics (NASDAQ:BDTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.87%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$22.55 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$167,500.00 Get BDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Black Diamond Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BDTX Insider Buying and Selling by Quarter Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Black Diamond Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/17/2023Growth N V BiotechMajor ShareholderBuy400,000$2.34$936,000.00 7/5/2023Ali BehbahaniDirectorBuy1,000,000$5.00$5,000,000.00 6/30/2023Growth N V BiotechMajor ShareholderBuy1,000,000$5.00$5,000,000.00 6/27/2023David M EpsteinInsiderSell25,000$6.70$167,500.00 6/27/2023Growth N V BiotechMajor ShareholderBuy1,740,000$5.49$9,552,600.00 10/27/2022Growth N V BiotechMajor ShareholderBuy191,678$1.87$358,437.86 Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW10/21/2022Growth N V BiotechMajor ShareholderBuy87,850$1.51$132,653.50 10/19/2022Growth N V BiotechMajor ShareholderBuy77,689$1.32$102,549.48 6/29/2022Fang NiInsiderBuy25,000$2.44$61,000.00 4/27/2022Growth N V BiotechMajor ShareholderBuy150,000$2.66$399,000.00 4/18/2022Growth N V BiotechMajor ShareholderBuy150,000$3.29$493,500.00 4/12/2022Growth N V BiotechMajor ShareholderBuy150,000$3.42$513,000.00 (Data available from 1/1/2013 forward) BDTX Insider Trading Activity - Frequently Asked Questions Who is on Black Diamond Therapeutics's Insider Roster? The list of insiders at Black Diamond Therapeutics includes Ali Behbahani, David M Epstein, Fang Ni, and Growth N V Biotech. Learn more on insiders at BDTX. What percentage of Black Diamond Therapeutics stock is owned by insiders? 8.87% of Black Diamond Therapeutics stock is owned by insiders. Learn more on BDTX's insider holdings. Which Black Diamond Therapeutics insiders have been buying company stock? The following insiders have purchased BDTX shares in the last 24 months: Ali Behbahani ($5,000,000.00), and Growth N V Biotech ($15,488,600.00). How much insider buying is happening at Black Diamond Therapeutics? Insiders have purchased a total of 4,140,000 BDTX shares in the last 24 months for a total of $20,488,600.00 bought. Which Black Diamond Therapeutics insiders have been selling company stock? The following insider sold BDTX shares in the last 24 months: David M Epstein ($167,500.00). How much insider selling is happening at Black Diamond Therapeutics? Insiders have sold a total of 25,000 Black Diamond Therapeutics shares in the last 24 months for a total of $167,500.00 sold. Black Diamond Therapeutics Key ExecutivesDr. Mark A. Velleca M.D. (Age 60)Ph.D., CEO, President & Chairman Compensation: $795.98kDr. David M. Epstein Ph.D. (Age 65)Co-Founder & Director Compensation: $969.69kDr. Fang Ni Pharm.D. (Age 37)CFO, Principal Financial Officer and Chief Business Officer Compensation: $665.98kDr. Sergey Yurasov M.D. (Age 55)Ph.D., Chief Medical Officer Compensation: $718.92kDr. Elizabeth Buck Ph.D. (Age 49)Co-Founder & Chief Scientific Officer Compensation: $340.47kMr. Brent Hatzis-Schoch Esq. (Age 59)J.D., COO & General Counsel Compensation: $683.29kMs. Elizabeth L. Montgomery (Age 52)Chief People Officer Ms. Melanie Morrison (Age 49)Chief Development Officer Ms. Erika Jones (Age 39)Senior VP of Finance & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Inhibrx Insider Ownership C4 Therapeutics Insider Ownership iTeos Therapeutics Insider Ownership Organogenesis Insider Ownership Astria Therapeutics Insider Ownership IGM Biosciences Insider Ownership Sana Biotechnology Insider Ownership Mereo BioPharma Group Insider Ownership Monte Rosa Therapeutics Insider Ownership ProKidney Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:BDTX) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
